GSK Consumer Healthcare Announces Completion of Solar Panel Project for Oak Hill Site in Partnership with Ameresco
The comprehensive solar panel project is
designed to generate electricity equivalent to more than 70% of the
Oak Hill site’s annual usage and reduce its carbon footprint by
GlaxoSmithKline (GSK) Consumer Healthcare and Ameresco, Inc.,
(NYSE: AMRC), a leading cleantech integrator specializing in energy
efficiency and renewable energy, today announced the completion of
a comprehensive solar panel project to serve GSK Consumer
Healthcare’s Oak Hill, New York site. The project enables GSK
Consumer Healthcare to reduce its carbon emissions.
This press release features multimedia. View
the full release here:
GSK Consumer Healthcare Announces
Completion of Solar Panel Project for Oak Hill Site in Partnership
with Ameresco that will generate electricity equivalent to more
than 70% of the Oak Hill site’s annual usage and reduce its carbon
footprint by 60%. (Photo: Business Wire)
Located in the scenic Catskill Mountains, the solar project near
the Oak Hill site, which produces some of GSK Consumer Healthcare’s
iconic oral health brands including Sensodyne, Pronamel, and
parodontax for the US and Canadian markets, comprises over 17,000
modules with an estimated electricity generation capacity of 6.9 MW
DC. This installation is designed to generate electricity
equivalent to more than 70% of the Oak Hill site’s annual usage and
reduce its carbon footprint by 60%.
“The completion of this project marks a pivotal moment for us at
GSK Consumer Healthcare, as a continued step in the right direction
for enacting real change that reduces our environmental impact and
helps us deliver on our larger sustainability initiatives,” said
Mike Allen, Sustainability Lead Consumer Health Supply Chain, GSK
Consumer Healthcare. “The Oak Hill site is the 12th solar
investment project for GSK and our Consumer Healthcare business,
and we plan to implement additional major solar and wind energy
investments in the UK and US to set us on track for 100% renewable
electricity by 2025. We are thrilled to share news of this exciting
milestone that we’ve reached working together with our partners and
are committed and excited to continue building a more sustainable
As the designated off-taker of the clean energy generated at the
solar site, the completed project demonstrates GSK Consumer
Healthcare’s larger ongoing commitment to its sustainability goals
of reducing its Scope 1 and 2 carbon emissions by 100% by 2030.
“In order to form a more sustainable world, we need to work
collaboratively with major corporations to implement
energy-efficient solutions. I’m so thankful that we were able to
work with an organization like GSK Consumer Healthcare, that has
set forth aggressive goals for its future and truly understands the
need to implement renewable technologies at a grand scale,” said
Pete Christakis, Senior Vice President, Ameresco.
Project construction was completed in April 2022.
For more information on GSK Consumer Healthcare’s environmental
commitments, visit www.gsk.com/en-gb/responsibility/environment/.
To learn more about the solar power solutions for commercial and
industrial project offered by Ameresco, visit
About Ameresco, Inc. Founded in 2000, Ameresco, Inc.
(NYSE:AMRC) is a leading cleantech integrator and renewable energy
asset developer, owner and operator. Our comprehensive portfolio
includes energy efficiency, infrastructure upgrades, asset
sustainability and renewable energy solutions delivered to clients
throughout North America and Europe. Ameresco’s sustainability
services in support of clients’ pursuit of Net Zero include
upgrades to a facility’s energy infrastructure and the development,
construction, and operation of distributed energy resources.
Ameresco has successfully completed energy saving, environmentally
responsible projects with Federal, state and local governments,
healthcare and educational institutions, housing authorities, and
commercial and industrial customers. With its corporate
headquarters in Framingham, MA, Ameresco has more than 1,000
employees providing local expertise in the United States, Canada,
and Europe. For more information, visit www.ameresco.com.
About GSK Consumer Healthcare GSK Consumer Healthcare
combines science and consumer insights to create innovative
world-class health care brands that consumers trust and experts
recommend for oral health, pain relief, respiratory and wellness.
For further information please visit www.gsk.com.
The announcement of achieving commercial operations for an
energy asset is not necessarily indicative of the timing or amount
of revenue from the energy asset, of the company’s overall revenue
for any particular period or of trends in the company’s overall
total assets in development or operation. This project was included
in our previously reported assets in development as of December 31,
version on businesswire.com: https://www.businesswire.com/news/home/20220426005540/en/
Media: Ameresco: Leila Dillon, 508-661-2264,
firstname.lastname@example.org GSK Consumer Healthcare: Sarah Miller,
Historical Stock Chart
From Jul 2022 to Aug 2022
Historical Stock Chart
From Aug 2021 to Aug 2022